La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
ADMA Biologics Gestione
Gestione criteri di controllo 3/4
ADMA Biologics' Il CEO è Adam Grossman, nominato in Jan2007, e ha un mandato di 17.58 anni. la retribuzione annua totale è $ 6.04M, composta da 12.4% di stipendio e 87.6% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 1.07% delle azioni della società, per un valore di $ 43.64M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 0.6 anni e 12.1 anni.
Informazioni chiave
Adam Grossman
Amministratore delegato
US$6.0m
Compenso totale
| Percentuale dello stipendio del CEO | 12.4% |
| Mandato del CEO | 17.6yrs |
| Proprietà del CEO | 1.1% |
| Durata media del management | less than a year |
| Durata media del Consiglio di amministrazione | 12.1yrs |
Aggiornamenti recenti sulla gestione
Recent updates
ADMA Biologics' (NASDAQ:ADMA) Strong Earnings Are Of Good Quality
Aug 16
ADMA Biologics: A Compelling GARP Stock For Biotech Investors
Jul 27ADMA Biologics, Inc. (NASDAQ:ADMA) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Jul 24Is ADMA Biologics (NASDAQ:ADMA) Using Too Much Debt?
Jul 17Is ADMA Biologics, Inc. (NASDAQ:ADMA) Trading At A 43% Discount?
May 30ADMA Biologics, Inc. Just Beat EPS By 45%: Here's What Analysts Think Will Happen Next
May 13Giving ADMA Biologics A Well-Deserved 'Booyah'
May 12ADMA Biologics, Inc.'s (NASDAQ:ADMA) Prospects Need A Boost To Lift Shares
May 08Is ADMA Biologics (NASDAQ:ADMA) A Risky Investment?
Apr 04Rising Margins And Product Promise Drive ADMA Biologics Forward (Rating Upgrade)
Apr 03ADMA Biologics: On A Roll Entering 2024
Jan 19Is There An Opportunity With ADMA Biologics, Inc.'s (NASDAQ:ADMA) 50% Undervaluation?
Jan 09ADMA Biologics, Inc. (NASDAQ:ADMA) Surges 30% Yet Its Low P/S Is No Reason For Excitement
Jan 09We Think ADMA Biologics (NASDAQ:ADMA) Has A Fair Chunk Of Debt
Oct 25We Think ADMA Biologics (NASDAQ:ADMA) Has A Fair Chunk Of Debt
Jun 10The Market Doesn't Like What It Sees From ADMA Biologics, Inc.'s (NASDAQ:ADMA) Revenues Yet
May 12ADMA Biologics: Strong Growth Is Clearing The Path To Profitability
Aug 21ADMA Biologics GAAP EPS of -$0.07, revenue of $33.9M
Aug 10ADMA Biologics (NASDAQ:ADMA) Is Carrying A Fair Bit Of Debt
Jun 01ADMA Biologics: A Path To Profits Looks Clear
May 12ADMA: Pertinent Updates
Apr 18ADMA Biologics' 2021 Numbers Showed Continued Strong Execution
Mar 29ADMA Biologics: 2021 Was Tough
Jan 18ADMA Biologics (NASDAQ:ADMA) Is Carrying A Fair Bit Of Debt
Dec 02ADMA Biologics: Turning A Corner
Nov 20ADMA: Insiders Showing Their Cards
Nov 02ADMA Biologics: Recent Significant Developments And Their Implications For The Stock
Aug 22Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$35m |
| Mar 31 2024 | n/a | n/a | -US$4m |
| Dec 31 2023 | US$6m | US$750k | -US$28m |
| Sep 30 2023 | n/a | n/a | -US$23m |
| Jun 30 2023 | n/a | n/a | -US$40m |
| Mar 31 2023 | n/a | n/a | -US$48m |
| Dec 31 2022 | US$3m | US$637k | -US$66m |
| Sep 30 2022 | n/a | n/a | -US$70m |
| Jun 30 2022 | n/a | n/a | -US$73m |
| Mar 31 2022 | n/a | n/a | -US$78m |
| Dec 31 2021 | US$4m | US$618k | -US$72m |
| Sep 30 2021 | n/a | n/a | -US$74m |
| Jun 30 2021 | n/a | n/a | -US$74m |
| Mar 31 2021 | n/a | n/a | -US$75m |
| Dec 31 2020 | US$2m | US$600k | -US$76m |
| Sep 30 2020 | n/a | n/a | -US$67m |
| Jun 30 2020 | n/a | n/a | -US$61m |
| Mar 31 2020 | n/a | n/a | -US$54m |
| Dec 31 2019 | US$2m | US$536k | -US$48m |
| Sep 30 2019 | n/a | n/a | -US$56m |
| Jun 30 2019 | n/a | n/a | -US$59m |
| Mar 31 2019 | n/a | n/a | -US$61m |
| Dec 31 2018 | US$2m | US$536k | -US$66m |
| Sep 30 2018 | n/a | n/a | -US$61m |
| Jun 30 2018 | n/a | n/a | -US$61m |
| Mar 31 2018 | n/a | n/a | -US$55m |
| Dec 31 2017 | US$3m | US$494k | -US$44m |
Compensazione vs Mercato: La retribuzione totale di Adam ($USD 6.04M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 6.76M ).
Compensazione vs guadagni: La retribuzione di Adam è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Adam Grossman (47 yo)
17.6yrs
Mandato
US$6,039,649
Compensazione
Mr. Adam S. Grossman serves as Director at BioFlorida Inc since August 2021. He is the Co-Founder of ADMA Biologics, Inc. and has been its Chief Executive Officer and President since October 2011 and 2007...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder | 17.6yrs | US$6.04m | 1.07% $ 45.3m | |
| Co-Founder & Vice Chairman of the Board | 17.6yrs | US$284.72k | 0.21% $ 9.1m | |
| CFO & Treasurer | less than a year | Nessun dato | 0.092% $ 3.9m | |
| COO & Senior VP of Compliance | less than a year | Nessun dato | 0.054% $ 2.3m | |
| Vice President of Marketing & Corporate Development | no data | Nessun dato | Nessun dato | |
| Executive Director of Sales | less than a year | Nessun dato | Nessun dato | |
| Executive Director of Human Resources | 2.6yrs | Nessun dato | Nessun dato | |
| Senior Director of Business Development & Corporate Strategy | no data | Nessun dato | Nessun dato |
0.6yrs
Durata media
49yo
Età media
Gestione esperta: Il team dirigenziale di ADMA non è considerato esperto (durata media 0.6 anni), il che suggerisce un nuovo team.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder | 17.6yrs | US$6.04m | 1.07% $ 45.3m | |
| Co-Founder & Vice Chairman of the Board | 17.6yrs | US$284.72k | 0.21% $ 9.1m | |
| Independent Director | 12.3yrs | US$280.72k | 0.026% $ 1.1m | |
| Independent Chairman | 17.6yrs | US$290.22k | 0.022% $ 954.7k | |
| Independent Director | 2.8yrs | US$272.34k | 0.12% $ 5.1m | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Independent Director | 12.1yrs | US$275.09k | 0.056% $ 2.4m | |
| Member of Scientific Advisory Board | 10.2yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | 10.2yrs | Nessun dato | Nessun dato | |
| Independent Director | less than a year | US$231.12k | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato |
12.1yrs
Durata media
59yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di ADMA è composto da personale esperto e esperto (durata media dell'incarico 12.1 anni).